Living longer, living better? Lessons from the Australian jurisdiction for dementia policy.

In a missive from the Australian Government, Department of Health, it is stated that,

Dementia is predicted to become the leading cause of disability in Australia by 2016. For these reasons, the Government will take a proposal to the next meeting of Commonwealth, State and Territory Health Ministers that dementia be added to the existing list of eight National Health Priorities.”

Indeed, their Government is introducing a new Dementia Supplement to provide additional financial assistance for dementia care in recognition of the additional costs involved. There will be a significant increase in the number of people eligible for additional assistance as a result of this measure.

This year, at the #ADI2104 conference currently being held in San Juan, Puerto Rico, Noriyo Washizu from the Alzheimer’s Association Japan described how people with dementia can need support and “care in all areas of life 24/7. To achieve Living well with dementia, both of the social resources to meet the special needs of PWDs and their families and case managements ability to utilize them with a sense of ethics are crucial. Along with the development of an aging society, case management in dementia is required to focus more on the whole community and to be more integrated.”

Considering dementia as a form of disability is an important policy issue. In the English jurisdiction, a disability has to be sustained for a certain arbitrary period of time to satisfy the case law. For a chronic progressive irreversible dementia, i.e. the vast majority of dementias such as Alzheimer’s disease, this is likely to be the case. This therefore throws the legal onus onto one of equality, as disability is a protected characteristic, and away from the more gimmicky offerings popular in the English jurisdiction which in reality offer no additional financial support for people with dementia or their carers.

Kate Swaffer, affiliated in this context to the University of South Australia, Adelaide, Australia, had a chance to present her ‘prescribed disengagement’ thesis on September 3 May 2014.

Kate described in November 2012 the following:

Following diagnosis, my specialists all told me ‘to give up work, give up study, and go home for the time I had left’! I quickly termed this prescribed disengagement, and thankfully I eventually chose to ignore it. Why is it that one day I was studying a double degree, working full time, volunteering, raising a family and running a household with my husband, and the next day, told to give up work, and give up life as I knew it, and start ‘living’? This prescribed dis-engagement sets up a chain reaction of defeat and fear, which negatively impacts a person’s ability to be positive, resilient and proactive.

She yesterday then described two models of care, one experience supporting continuing engagement, including employment for people with younger onset dementia; the medical model of Prescribed Disengagement versus the disAbility model of Continuing Engagement used in universities.

Following a diagnosis of younger onset dementia, Kate was advised to give up work, give up tertiary studies, and go home to live for the time she had left. It was at this time she termed this Prescribed Disengagement.

Kate writes in her abstract,

“The medical model of care prescribed disengaging from my pre-diagnosis life, which supports and exacerbates social inequality, stigma, isolation and discrimination. If I had been advised to use the disability model of care beyond my university campus, I would have been able to remain in paid employment, and if the symptoms of dementia were seen as disabilities, my employer would have been legally obliged to support continuing employment.”

This is significant from a policy perspective. If there were a system of ‘care coordinators’, perhaps who had especial expertise in advocacy for issues concerning the dementias, it might be that such coordinators could lobby local authorities for financial support so that they could meet their legal obligations in making ‘reasonable adjustments’ for people with dementia. This should not be something that people with dementia should be expected to ‘fight for’. It should be an essential aspect of dementia care and support provision.

Kate also briefly discussed a volunteering project in Adelaide South Australia which supports “the disability model of care.”

Kate writes,

“Treating the symptoms of dementia as disabilities rather than managing them in ways that restrict are vital to well-being, quality of life and motivation. The significant and positive social and financial impact on the person with dementia, their families, and society of being able to stay meaningfully engaged, as well as choosing to remain employed, and its impact on a person’s quality of life, is the final topic of this presentation. ”

And this, ladies and gentlemen, is what I believe policy should be heading to.

Not ‘counting the cost’ of people with dementia, framing the article as a financial burden we should all resent paying for, but valuing the contribution of people with dementia and close caregivers for what they can bring to society in a whole manner of ways.

And of course people with dementia need to be recognised as individuals, with diversity. The massive problem with the term ‘dementia friendly’ is that it encourages a notion of dementia as a homogeneous mass with all one big diagnosis, label and severity, and encourages a ‘them against us’ approach. Being inclusive and integrated are not necessarily the same.

Diversity

A lack of patients’ or carers’ representative on the World Dementia Council is either an oversight or is entirely deliberate

In fairness, there’s nothing ambiguous about the stated intentions of the ‘World Dementia Council‘.

“The creation of a World Dementia Council was one of the main commitments made at the G8 dementia summit in December 2013. The council aims to stimulate innovation, development and commercialisation of life enhancing drugs, treatments and care for people with dementia, or at risk of dementia, within a generation.”

In the UK jurisdiction, there is much deep concern about the extent to which policy should be driven towards a ‘cure’ or ‘care’ for dementia.

Only this week, another story about poor standards in an English care home hit the headlines.

An undercover reporter had filmed a video appearing to show a partially paralysed woman being slapped at The Old Deanery at Bocking, near Braintree. The home’s owners have now sacked a total of seven staff and suspended one other. Essex Police said an investigation of the alleged abuse had been launched after detectives viewed the programme.

The reports of closure of day clubs and small social enterprises losing tenders stream in every week.

Meanwhile, in “Dementia Friends”, which is led by the Alzheimer’s Society, people will be given free awareness sessions to help them understand dementia better and become Dementia Friends.

By 2015, 1 million people will become Dementia Friends. The £2.4 million programme is funded by the Social Fund and the Department of Health. The scheme has been launched in England, and the Alzheimer’s Society is hoping to extend it to the rest of the UK soon.

It could be a genuine belief that industry leaders in economics, Pharma and innovations feel they do not need to listen to the views  of persons with dementia or carers.

But I totally reject this hypothesis.

It is a huge kick in the teeth not to have representatives on a body actually called the “World Dementia Council”.

It is impossible for Pharma, whose primary duty is admittedly to their shareholders, to enter the ‘dementia market’ without an understanding of the needs of the market involved.

Furthermore, all innovations need to be adopted.

The work of Prof Roger Orpwood, Emeritus Professor of Medical Engineering at Bristol, is well known to many experts in dementia innovations.

Orpwood recently retired as Director of the Bath Institute of Medical Engineering (BIME) after a career in engineering design and research, initially in Industry, and then in academia and the health service.

His groundbreaking work is cited in my book “Living well with dementia”, not least because his assistive technologies for dementia through his research grants have been amazing.

I also admire the painstaking way in which he tested all his assistive technology adaptations with actual persons with dementia. This is explained in great detail in all Orpwood’s peer-reviewed papers which I have cited in my references.

I have previous reported a straw electronic poll on who were the ‘winners and losers’ of the G8 dementia summit.

96 people took part. The results clearly showed that the vast majority of people thought that large charities, corporate finance and the pharmaceutical industry were clear winners. People with dementia and carers were the clear losers, in perception.

Consistent with this, the #G8dementia summit contained little in the way of patients’ or carers’ representations relative to the needs of corporate finance, Pharma-directed research and Pharma, in the discussion sessions.

The few that appeared were outstanding through, for example Beth Britton asked a focused question on the need for more research into psychological intervention. This feeds in fact into the point there are no patients or carers representatives on the World Dementia Council, making it far less likely for high quality research into living well with dementia – which we desperately need – to be mandated.

On a happier note, Peter Dunlop gave an outstanding speech wihich received a standing ovation.

And Beth’s video was extremely special indeed for many of us.

But an explanation for the lack of patients’ and carers’ representatives on the World Dementia Council can perhaps be found in the original raison d’être of the G8 dementia summit.

A BBC News website headline proudly boasts from 10 October 2012, “Hope over dementia summit boost to ailing industry‘.

Likewise, there were no patients or carers representatives at the G8 dementia summit itself, held last year in December 2012.

The general impression from my survey was that the G8 dementia summit was a ‘great opportunity’, but also a ‘waste’.

In the court of public opinion, and bear in mind that politicians and the pharmaceutical industry get their moral license to practise from their democratic acceptance, this lack of representation on the World Dementia Council has gone down like a ‘lead balloon’.

It’s simply untrue there’s a lack of good candidates of people living with dementia who could have done a brilliant job of representing views of people: Kate Swaffer and Richard Taylor immediately spring to mind.

All these shenanigans from the UK government-led policy are in total contrast to the enormous amount of warmth, goodwill and enthusiasm from the Dementia Alliance International, a stakeholder group led by people with dementia, at the Alzheimer’s Disease International conference currently under way in San Juan as we speak.

DAI15DAI11

the panel

Whatever the rationale for the decision, it is incredibly bad PR for the “World Dementia Council”, raising serious questions about accountability, transparency and governance like the Prime Minister’s Dementia Challenge itself.

Jo's comment

It is essential to make clear all potential conflicts of interests known of these clearly well connected people on the Council.

And if you think I am a lone voice.

I am not.

Here’s JeanGeorges CEO of Alzheimer’s Europe (@JeanGeorgesAE):

Things can only get better. Hopefully.

 

 

 

Appendix

Members appointed include

Sir William Castell, Chairman of the Wellcome Trust

Dame Sally Davies, Chief Medical Officer at theDepartment of Health

Tim Evans, Director for Health, Nutrition and Population at the World Bank

Franz Humer, Chairman of Diageo plc

Dr Yves Joanette, Scientific Director, Canadian Institute of Health Research, Institute of Aging

Professor Martin KnappLondon School of Economics

Dr Kiyoshi Kurokawa, Professor of the National Graduate Institute for Policy Studies and Science Advisor to the Cabinet of Japan

Yves Leterme, Deputy Secretary General of theOECD (The Organisation for Economic and Co-operation and Development)

Raj Long, Senior Regulatory Officer – Integrated Development, Global Health at the Bill & Melinda Gates Foundation

Professor Pierluigi Nicotera, Scientific Director and Chairman of the Executive Board at the German Centre for Neurodegenerative Diseases (DZNE)

Professor Ronald PetersenMayo Alzheimer’s Disease Research Center

Paul Stoffels, Worldwide Chairman, Pharmaceuticals,Johnson & Johnson

George Vradenburg, President and Chairman of theVradenburg Foundation and US Against Alzheimer’s

 

Really proud of my friends living well with dementia at #ADI2014 Puerto Rico

29th International Conference of Alzheimer’s Disease International
Dementia: Working Together for a Global Solution
1-4 May 2014, San Juan, Puerto Rico

ADI and Asociacion de Alzheimer y Desordenes Relacionados de Puerto Rico invite representatives from around the world, from medical professionals and researchers to people with dementia and carers, all with a common interest in dementia.

The conference programme – details given on this website – has streams including research, advocacy and care.

I am particularly proud of my close friend, Kate Swaffer (@KateSwaffer).

Kate is in a volunteer advocacy position, also working as a consumer on the National Advisory Consumers Committee, and the Consumer’s Dementia Research Network.

She contributes so much value to the people who are lucky to know her.

Kate lives in Adelaide, Australia. She loves cats like me. She has a formidable interest and experience in many things such as academia, media, clinical quality, and cuisine. She happens to live with first-hand experience of living with a dementia, and is a sheer joy to learn off.

Dementia Alliance International is a non-profit group of people with dementia from the USA, Canada, Australia and other countries that seek to represent, support, and educate others living with the disease, and an organization that will provide a unified voice of strength, advocacy and support in the fight for individual autonomy and improved quality of life.

Their membership is open to anyone with any type of dementia. Click here to inquire about membership. 

PHOTOS ALL BY KATE SWAFFER APART FROM THE ONES WITH KATE IN THEM

DAI11

 

DAI15

DAI10

DAI13

DAIDAI2DAI3

must go in

Kate sporting a very important message for those of us who are passionate about a person-centred approach promoting living well with dementia.

This philosophy does not give undue priority to a medical model which pushes drugs which currently have very modest effects, or certain vested interests.

Living well with dementia in the English jurisdiction is a policy plank I’ve extensively reviewed for the English jurisdiction here.

DAI4DAI5DAI6DAI7DAI8

dai12

A wonderful picture of Kate and Gill (@WhoseShoes). I am very proud of them having made this global journey to Puerto Rico.

DAI9

Adorable

And here’s Gill encouraging full participation!

DAI14

The review of my book “Living well with dementia” today in Nursing Times

Thanks very much to the team at @NursingTimes for the first review of my book “Living well with dementia”.

I am hugely honoured.

 

This review was first posted on the page http://www.nursingtimes.net/opinion/book-club/living-well-with-dementia/5070460.blog?blocktitle=Nursing-Book-club&contentID=8080 in the “Book club” series of the magazine.

 

1 May, 2014

Title: Living Well with Dementia

Author: Shibley Rahman

Publisher: Radcliffe Publishing

Reviewer: Nigel Jopson, home manager, Birdscroft Nursing Home, Ashtead, Surrey

What was it like?

A meaty 300 plus pages book that attempt to cover all aspects of the dementia experience and it succeeds. It looks at the concept of living well what it is, how to measure it and how to develop services and attitudes to incorporate it. The book is up to date and relevant and has excellent sources and references. There are parts that can act as an instruction manual for good practice such as the suggestions about dealing with consent in chapter 11. A definite “cut out and keep” piece. Probably the most useful book I have read this year.

What were the highlights? 

It covers everything you are likely to encounter in an accessible and informative way. It is nice to see some comments on ward design rather than purely care home as is more common.

My favourite part was in the conclusion where the author says “…writing a book on wellbeing in dementia is an impossible task.” I believe that may be the only part where she is wrong as this book is fabulous.

Strengths & weaknesses:

An enormous amount of information presented well and user friendly. I was worried it may have been too academic but it was not. It has good references and I particularly liked the way it attempted to integrate the whole idea and encouraged the use of other sources.

Who should read it?

This book should be essential reading for anybody with any contact with people living with dementia, which realistically I suppose means everybody. It can help towards a better understanding not only of dementia but the ways that peoples’ lives can be improved and enriched with a little effort and knowledge.

Living well with dementia